Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,771

Stocks News & Analysis

stocks

Is this the $80 billion elephant Warren Buffett has been waiting for?

Morningstar’s Greg Warren says Berkshire may have little choice but to take a hard look at this huge potential acquisition.
stocks

Tesla: Board announces new pay package for CEO Elon Musk

A key provision of the new award is that Musk must remain in a senior leadership position at Tesla.
stocks

New ASX share on our best ideas list

This undervalued miner is unappreciated by the market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,021.7099.701.12%
CAC 407,632.0185.851.14%
DAX 4023,757.69331.721.42%
Dow JONES (US)44,173.64585.061.34%
FTSE 1009,128.3059.720.66%
HKSE24,774.5141.060.17%
NASDAQ21,053.58403.451.95%
Nikkei 22540,607.38316.680.79%
NZX 50 Index12,838.27154.231.22%
S&P 5006,329.9491.931.47%
S&P/ASX 2008,763.1099.401.15%
SSE Composite Index3,602.1318.820.53%

Market Movers